XYMOGEN Launches Pharmaceutix™ Medical Foods Division and Partners with Acasti Pharma to Bring Revolutionary Medical Food to United States and Beyond

ORLANDO, Fla. – Wednesday, July 11, 2012 – XYMOGEN announced today an exclusive partnership with Acasti Pharma, the biopharmaceutical company with whom they will launch the worldwide distribution of LipiChol540™, a physician-prescribed medical food to manage omega-3 phospholipid deficiency. The formula will be distributed by Pharmaceutix Medical Foods, a wholly owned subsidiary of XYMOGEN. Acasti, which is headquartered in Canada, was the first to discover the effects of phospholipids, a major component of cell membranes essential for all vital cell processes. The company is a pioneer in